Debruyne FM - Search Results

1

BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale, design, and interim analysis of the trial of the South-East Cooperative Urological Group, The Netherlands.

Witjes WP, van der Meijden PM, Roos EP, Witjes JA, Steerenberg PA, Doesburg W, Debruyne FM. Witjes WP, et al. Among authors: debruyne fm. Prog Clin Biol Res. 1992;378:59-67. Prog Clin Biol Res. 1992. PMID: 1301587 Clinical Trial. No abstract available.

2

Intravesical chemotherapy for superficial bladder cancer.

Witjes JA, Debruyne FM. Witjes JA, et al. Among authors: debruyne fm. Nat Clin Pract Urol. 2004 Dec;1(2):56-7. doi: 10.1038/ncpuro0009. Nat Clin Pract Urol. 2004. PMID: 16474497 No abstract available.

3

BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale and design of the trial of the Southeast Co-operative Urological Group, The Netherlands.

van der Meijden PM, Debruyne FM, Steerenberg PA, de Jong WH, Doesburg W. van der Meijden PM, et al. Among authors: debruyne fm. Prog Clin Biol Res. 1989;310:285-98. Prog Clin Biol Res. 1989. PMID: 2505272 Clinical Trial. No abstract available.

4

Aspects of non-specific immunotherapy with BCG in superficial bladder cancer: an overview.

van der Meijden AP, Debruyne FM, Steerenberg PA, de Jong WH. van der Meijden AP, et al. Among authors: debruyne fm. Prog Clin Biol Res. 1989;310:11-33. Prog Clin Biol Res. 1989. PMID: 2672011 Review. No abstract available.

5

Intravesical BCG administration in the guinea pig. Histomorphological aspects.

van der Meijden AP, de Jong WH, Steerenberg PA, Debruyne FM, Ruitenberg JE. van der Meijden AP, et al. Among authors: debruyne fm. Prog Clin Biol Res. 1989;310:67-79. Prog Clin Biol Res. 1989. PMID: 2672024 No abstract available.

6

Bladder carcinoma in patients less than 40 years of age.

Witjes JA, Debruyne FM. Witjes JA, et al. Among authors: debruyne fm. Urol Int. 1989;44(2):81-3. doi: 10.1159/000281475. Urol Int. 1989. PMID: 2728130

7

BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.

Debruyne FM, van der Meijden AP, Schreinemachers LM, Geboers AD, Franssen MP, van Leeuwen MJ, Steerenberg PA, de Jong WH, Ruitenberg EJ. Debruyne FM, et al. Prog Clin Biol Res. 1988;269:511-24. Prog Clin Biol Res. 1988. PMID: 3134662 Clinical Trial. No abstract available.

8

BCG (RIVM) versus mitomycin intravesical therapy in superficial bladder cancer. First results of randomized prospective trial.

DeBruyne FM, van der Meijden AP, Geboers AD, Franssen MP, van Leeuwen MJ, Steerenberg PA, de Jong WH, Ruitenberg JJ. DeBruyne FM, et al. Urology. 1988 Mar;31(3 Suppl):20-5. Urology. 1988. PMID: 3279698 Clinical Trial.

9

Risk factors in carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.

van Gils-Gielen RJ, Witjes WP, Caris CT, Debruyne FM, Witjes JA, Oosterhof GO. van Gils-Gielen RJ, et al. Among authors: debruyne fm. Urology. 1995 Apr;45(4):581-6. doi: 10.1016/s0090-4295(99)80047-8. Urology. 1995. PMID: 7716838 Clinical Trial.

10

A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder.

Vegt PD, Witjes JA, Witjes WP, Doesburg WH, Debruyne FM, van der Meijden AP. Vegt PD, et al. Among authors: debruyne fm. J Urol. 1995 Mar;153(3 Pt 2):929-33. J Urol. 1995. PMID: 7853577 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

666 results

Search Page

Filters